Literature DB >> 18853247

Improvement in strategies for the non-invasive prenatal diagnosis of Huntington disease.

M Cristina González-González1, Maria Garcia-Hoyos, M Jose Trujillo-Tiebas, A Bustamante Aragonés, M Rodriguez de Alba, D Diego Alvarez, Joaquín Diaz-Recasens, Carmen Ayuso, Carmen Ramos.   

Abstract

PURPOSE: We focused on the improvements of prenatal diagnosis by the analysis of DNA from maternal plasma, using Huntington disease as a model of disease.
METHODS: We studied plasma from a pregnancy at risk of having a fetus affected with Huntington disease by the use of two direct analysis of the mutation and polymorphic STRs.
RESULTS: Direct methods were not informative. Analysis with STRs revealed the presence of the allele that does not co-segregate with the disease, thus the fetus was healthy.
CONCLUSIONS: This strategy is very useful to face complex cases when the direct study is not informative not only for Huntington disease but also for many other disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853247      PMCID: PMC2582097          DOI: 10.1007/s10815-008-9256-8

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  13 in total

1.  Early Huntington disease prenatal diagnosis by maternal semiquantitative fluorescent-PCR.

Authors:  M C González-González; M J Trujillo; M Rodríguez de Alba; C Ramos
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

2.  Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers.

Authors:  A Bustamante-Aragones; M Rodriguez de Alba; C Gonzalez-Gonzalez; M J Trujillo-Tiebas; D Diego-Alvarez; E Vallespin; J Plaza; C Ayuso; C Ramos
Journal:  Haemophilia       Date:  2008-03-04       Impact factor: 4.287

3.  Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia.

Authors:  Y M Lo; T N Leung; M S Tein; I L Sargent; J Zhang; T K Lau; C J Haines; C W Redman
Journal:  Clin Chem       Date:  1999-02       Impact factor: 8.327

4.  Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR.

Authors:  M C González-González; M J Trujillo; M Rodríguez de Alba; M García-Hoyos; I Lorda-Sánchez; J Díaz-Recasens; C Ayuso; C Ramos
Journal:  Prenat Diagn       Date:  2003-03       Impact factor: 3.050

Review 5.  Fetal RhD genotyping from maternal plasma.

Authors:  Y M Lo
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

6.  Singleton births after routine preimplantation genetic diagnosis using exclusion testing (D4S43 and D4S126) for Huntington's disease.

Authors:  Melinda J Jasper; Dong Gui Hu; Jan Liebelt; Deborah Sherrin; Robert Watson; Kelton P Tremellen; Nicole D Hussey
Journal:  Fertil Steril       Date:  2006-03       Impact factor: 7.329

7.  Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma.

Authors:  M C González-González; M García-Hoyos; M J Trujillo; M Rodríguez de Alba; I Lorda-Sánchez; J Díaz-Recasens; E Gallardo; C Ayuso; C Ramos
Journal:  Prenat Diagn       Date:  2002-10       Impact factor: 3.050

Review 8.  Prenatal screening of single-gene disorders from maternal blood.

Authors:  A Sekizawa; H Saito
Journal:  Am J Pharmacogenomics       Date:  2001

9.  A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing.

Authors:  S E Andrew; Y P Goldberg; J Theilmann; J Zeisler; M R Hayden
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

10.  Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.

Authors:  S Creighton; E W Almqvist; D MacGregor; B Fernandez; H Hogg; J Beis; J P Welch; C Riddell; R Lokkesmoe; M Khalifa; J MacKenzie; A Sajoo; S Farrell; F Robert; A Shugar; A Summers; W Meschino; D Allingham-Hawkins; T Chiu; A Hunter; J Allanson; H Hare; J Schween; L Collins; S Sanders; C Greenberg; S Cardwell; E Lemire; P MacLeod; M R Hayden
Journal:  Clin Genet       Date:  2003-06       Impact factor: 4.438

View more
  7 in total

1.  Non-invasive prenatal detection of achondroplasia using circulating fetal DNA in maternal plasma.

Authors:  Ji Hyae Lim; Mee Jin Kim; Shin Young Kim; Hye Ok Kim; Mee Jin Song; Min Hyoung Kim; So Yeon Park; Jae Hyug Yang; Hyun Mee Ryu
Journal:  J Assist Reprod Genet       Date:  2010-10-21       Impact factor: 3.412

2.  Noninvasive prenatal diagnosis of β-thalassemia by relative haplotype dosage without analyzing proband.

Authors:  Haoxian Li; Bole Du; Fuman Jiang; Yulai Guo; Yang Wang; Chunsheng Zhang; Xiaojing Zeng; Yuhuan Xie; Shuming Ouyang; Yexing Xian; Min Chen; Weiqiang Liu; Xiaofang Sun
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

3.  Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for noninvasive prenatal diagnosis.

Authors:  Peter B Gahan
Journal:  Int J Womens Health       Date:  2013-04-17

Review 4.  Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects.

Authors:  Peter Benn
Journal:  J Clin Med       Date:  2014-05-21       Impact factor: 4.241

5.  Non-Invasive Prenatal Diagnosis in the Management of Preimplantation Genetic Diagnosis Pregnancies.

Authors:  Ana Bustamante-Aragones; Sara Perlado-Marina; Maria José Trujillo-Tiebas; Jesús Gallego-Merlo; Isabel Lorda-Sanchez; Luz Rodríguez-Ramirez; Concepcion Linares; Corazón Hernandez; Marta Rodriguez de Alba
Journal:  J Clin Med       Date:  2014-08-14       Impact factor: 4.241

6.  Fetal Genotyping in Maternal Blood by Digital PCR: Towards NIPD of Monogenic Disorders Independently of Parental Origin.

Authors:  Sara Perlado; Ana Bustamante-Aragonés; Marta Donas; Isabel Lorda-Sánchez; Javier Plaza; Marta Rodríguez de Alba
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

Review 7.  Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers.

Authors:  Valentina Karin-Kujundzic; Ida Marija Sola; Nina Predavec; Anamarija Potkonjak; Ema Somen; Pavao Mioc; Alan Serman; Semir Vranic; Ljiljana Serman
Journal:  Cells       Date:  2019-11-18       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.